+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Diagnostic and Therapeutic Developments across Global Healthcare

  • ID: 4244281
  • Report
  • May 2017
  • Region: Global
  • 15 pages
  • Frost & Sullivan
This Genetic Technology TOE depicts recent diagnostic and therapeutic advances across the global healthcare industry. Clinical trial scenario for monoclonal antibody therapies for migraine are also depicted.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Note: Product cover images may vary from those shown
1. Recent Diagnostic and Therapeutic Advances
  • Advancing Epigenetic and Molecular Diagnostics across Urologic and Lung Cancers
  • Expanded Collaboration for Novel Migraine Antibody Platform
  • 3D Scaffold Platform for Organ Transplants
  • Mobile App for Diabetes Management
2. Clinical Trial Analysis and Industry Interactions
  • Clinical Trial Analysis
  • Industry Interactions
Note: Product cover images may vary from those shown